Paul Andrew Moore, Chief Scientific Officer at Zymeworks Inc. (ZYME), sold 9,799 shares at $10.65 ($106K) on 2024-01-05, disclosed to the SEC on 2024-01-08.
Open-market sale of $106k ZYME by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.65 | 7,460 | $79K | 75.2% |
| 2 | $11.22 | 2,339 | $26K | 24.8% |
| Total | $10.79 avg | 9,799 | $106K | 100% |
| Filing → |
| ZYME | SELL | 2025-01-06 | $633K | — | Filing → |